
HOPE Therapeutics Deploys AI-Driven Navigation for TMS Treatments
A patient in Sarasota has become the first to receive treatment using the FDA-cleared Zeta TMS Navigation System, marking a shift toward sub-millimetric precision in outpatient psychiatric care. The rollout, spearheaded by HOPE Therapeutics, integrates advanced computer vision into standard workflows for managing treatment-resistant depression.






















